Oral Diseases and Disorders Research in Maryland
Oral Diseases and Disorders Research (93.121) awarded $53.0 million to recipients in Maryland in 67 grants from fiscal 2021 to 2025, 2.9% of the program's national total. University of Maryland, Baltimore received the most, $26.8 million.
- Awarded in Maryland$53.0 million
- Awards67
- Share of the program2.9%
- Rank among states10th of 48
- National total$1.9 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 26 | $9.8 million |
| FY 2022 | 29 | $11.0 million |
| FY 2023 | 31 | $13.5 million |
| FY 2024 | 29 | $9.1 million |
| FY 2025 | 29 | $9.7 million |
Recipients in Maryland
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Maryland, Baltimore | Colleges and universities | 26 | $26.8 million |
| The Johns Hopkins University | Colleges and universities | 27 | $18.0 million |
| Rise Therapeutics LLC | Small businesses | 2 | $3.3 million |
| Pediametrix Inc. | Small businesses | 2 | $3.1 million |
| University of Maryland, College Park | Colleges and universities | 3 | $1.0 million |
| University of Maryland Es | Colleges and universities | 1 | $312,000 |
| MS Technologies Corp | Small businesses | 1 | $299,704 |
| Morgan State University | Colleges and universities | 1 | $71,815 |
| United States Association for the Study of Pain Inc | Nonprofits | 3 | $21,000 |
| Federation of American Societies for Experimental Biology | Nonprofits | 1 | $3,000 |
Open opportunities under this program
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
See all 88 on the program page
Questions people ask
How much Oral Diseases and Disorders Research money goes to Maryland?
$53.0 million from fiscal 2021 to 2025, across 67 awards. Maryland ranks 10th of 48 states and territories for this program.
Who receives Oral Diseases and Disorders Research money in Maryland?
The largest recipient is University of Maryland, Baltimore, with $26.8 million in 26 awards. Next are The Johns Hopkins University and Rise Therapeutics LLC.
Can organizations in Maryland apply now?
Yes, 88 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Oral Diseases and Disorders Research in other states
Other large programs in Maryland
- Grants to States for Medicaid
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Education Stabilization Fund
- Highway Planning and Construction
- USAID Foreign Assistance for Programs Overseas
- 1332 State Innovation Waivers
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies